Global In Vitro Diagnostic Market Analysis by RNCOS

VIEWS: 189 PAGES: 127

More Info
									RNCOS                      Global In Vitro Diagnostic Market Analysis
Online Business Research
RNCOS                                                         Global In Vitro Diagnostic Market Analysis
Online Business Research




                                               Published by




                             RNCOS E-Services Pvt. Ltd.
                                     B -129, Sector 6, Noida - 201301
                                         Tel: +91 (120) 4224700
                                          Email: info@rncos.com
                                             www.rncos.com




                              © Global In Vitro Diagnostic Market Analysis
                                                RNCOS, 2010
                                                  Edition 3.0
                              All rights reserved. This publication is protected
                           by copyright. No part of it may be reproduced, stored
                           in a retrieval system or transmitted, in any form or by
                             any means, electronic mechanical, photocopying,
                               recording or otherwise without the prior written
                                         permission of the publishers.
RNCOS                                                                  Global In Vitro Diagnostic Market Analysis
Online Business Research




                                                            !""#                                    $!"" %


&                                                       '                      !   "   #        $    ! !(        )
    )
                    *                                                                   +
              *                             ,&- .            #         !"/")!"/!
        +


0                                                     ) )                              1
                                2                                                               +


                                        *
                        +


                                                                   *


3                               4                                  +
                                                    $!"/")!"/!%


0
                            *                                                                                *


                                    *                                                       *
                                        *      4
                                                                                                *
RNCOS                                      Global In Vitro Diagnostic Market Analysis
Online Business Research




                           +           *
                                                                              5
                               *             6     &         7




                                   %
RNCOS                                                                                     Global In Vitro Diagnostic Market Analysis
Online Business Research




                                                                 Table of Contents

1.    Analyst View ......................................................................................................................................10
2.    Research Methodology ....................................................................................................................12
3.    In Vitro Diagnostic Market Overview ..............................................................................................13
   3.1      Introduction.................................................................................................................................13
   3.2      What is In Vitro Diagnostics? .....................................................................................................14
   3.3      Market Size and Growth.............................................................................................................16
4.    Market Drivers ...................................................................................................................................18
   4.1      Chronic and Infectious Diseases................................................................................................18
   4.2      New Technologies......................................................................................................................19
   4.3      Emerging Markets ......................................................................................................................20
   4.4      Diversifying Applications ............................................................................................................21
   4.5      Healthcare Infrastructure............................................................................................................22
5.    Clinical Segmentation Outlook 2012...............................................................................................23
   5.1      Point-of-Care Diagnostics ..........................................................................................................25
   5.2      Clinical Chemistry and Immunochemistry..................................................................................29
   5.3      Molecular Diagnostics ................................................................................................................32
   5.4      Microbiology ...............................................................................................................................36
   5.5      Hemostasis.................................................................................................................................38
   5.6      Hematology ................................................................................................................................41
   5.7      Immunohematology....................................................................................................................43
6.    Segmentation by Indication (Current and Future Scenario - 2012) .............................................45
   6.1      Diabetes .....................................................................................................................................45
   6.2      Cardiovascular ...........................................................................................................................48
   6.3      Cancer........................................................................................................................................50
   6.4      HIV .............................................................................................................................................52
   6.5      Tuberculosis ...............................................................................................................................53
   6.6      Influenza.....................................................................................................................................55
7.    Geographical Segmentation (Current and Future Scenario - 2012) ............................................57
   7.1      North America ............................................................................................................................59
      7.1.1 United States .........................................................................................................................59
      7.1.2 Canada ..................................................................................................................................62
   7.2      Europe........................................................................................................................................64
      7.2.1 Germany ................................................................................................................................66
      7.2.2 France....................................................................................................................................69
      7.2.3 Italy ........................................................................................................................................72
      7.2.4 United Kingdom .....................................................................................................................75
      7.2.5 Spain ......................................................................................................................................77
      7.2.6 Other European Countries .....................................................................................................79
   7.3      Japan..........................................................................................................................................80
   7.4      Rest of the World .......................................................................................................................83
      7.4.1 China......................................................................................................................................83
      7.4.2 India .......................................................................................................................................86
      7.4.3 Turkey ....................................................................................................................................90
      7.4.4 Brazil ......................................................................................................................................93
      7.4.5 Mexico....................................................................................................................................96
8.    Consumer Behavior Analysis ..........................................................................................................99
9.    Emerging Sectors ...........................................................................................................................102
   9.1      Companion Diagnostics/Theranostics .....................................................................................102
   9.2      Nanodiagnostics.......................................................................................................................105
10. Recent Developments and M&As..................................................................................................107
11. Industry Restraints .........................................................................................................................109
   11.1     Regulatory and Reimbursement Issues...................................................................................109
   11.2     R&D and Short Product Lifecycle.............................................................................................111
   11.3     Cost Control .............................................................................................................................113


                                                                            &
RNCOS                                                                              Global In Vitro Diagnostic Market Analysis
Online Business Research




12. Competitive Landscape..................................................................................................................114
  12.1   Market Share of Top Players ...................................................................................................114
  12.2   Key Player Profile.....................................................................................................................116
    12.2.1    Roche Holding Ltd. ..........................................................................................................116
    12.2.2    Abbott Laboratories .........................................................................................................118
    12.2.3    Siemens AG ....................................................................................................................120
    12.2.4    Beckman Coulter .............................................................................................................122
    12.2.5    Ortho-Clinical Diagnostics ...............................................................................................125




                                                                      '
RNCOS                                                                                        Global In Vitro Diagnostic Market Analysis
Online Business Research




List of Figures:

Figure 3-1: Global - In Vitro Diagnostic Market (Billion US$), 2008 & 2009 ...............................................16
Figure 3-2: Global - Forecast for In Vitro Diagnostic Market (Billion US$), 2010-2012 ..............................17
Figure 5-1: Global - In Vitro Diagnostic Market by Clinical Segment (%), 2009 .........................................23
Figure 5-2: Global - Forecast for In Vitro Diagnostic Market by Clinical Segment (%), 2012 .....................24
Figure 5-3: Global - Point of Care Diagnostic Market (Billion US$), 2008 & 2009......................................26
Figure 5-4: Global - Point of Care Diagnostic Market by Segment (%) ......................................................26
Figure 5-5: Global - Point of Care Diagnostic Market by Distribution (%), 2007.........................................27
Figure 5-6: Global - Forecast for Point of Care Diagnostic Market (Billion US$), 2010-2012.....................28
Figure 5-7: Global - Clinical Chemistry and Immunochemistry Market (Billion US$), 2007-2009 ..............30
Figure 5-8: Global - Forecast for Clinical Chemistry and Immunochemistry Market (Billion US$), 2010-
2012.............................................................................................................................................................31
Figure 5-9: Global - Molecular Diagnostic Market (Billion US$), 2007-2009 ..............................................33
Figure 5-10: Global - Forecast for Molecular Diagnostic Market (Billion US$), 2010-2012 ........................34
Figure 5-11: Global - Microbiology Diagnostic Market (Billion US$), 2008 & 2009.....................................36
Figure 5-12: Global - Forecast for Microbiology Diagnostic Market (Billion US$), 2010-2012 ...................37
Figure 5-13: Global - Hemostasis Diagnostic Market (Billion US$), 2008 & 2009 ......................................39
Figure 5-14: Global - Forecast for Hemostasis Diagnostic Market (Billion US$), 2010-2012 .....................40
Figure 5-15: Global - Forecast for Hematology Market (Billion US$), 2010-2012 ......................................42
Figure 5-16: Global - Immunohematology Diagnostic Market (Billion US$), 2007-2009 ............................43
Figure 5-17: Global - Forecast for Immunohematology Diagnostic Market (Billion US$), 2010-2012 ........44
Figure 6-1: Global - Forecast for Diabetic Population (Million), 2010 & 2030 .............................................45
Figure 6-2: Global - Blood Glucose Monitoring Market (Billion US$), 2007-2009.......................................46
Figure 6-3: Global - Forecast for Blood Glucose Monitoring Market (Billion US$), 2010-2012 ..................46
Figure 6-4: Global - Cardiovascular Diagnostic and Therapies Market (Billion US$), 2007-2009..............48
Figure 6-5: Global - Forecast for Cardiovascular Diagnostic and Therapies Market (Billion US$), 2010-
2012.............................................................................................................................................................49
Figure 6-6: Global - Cancer Diagnostic Market (Billion US$), 2008 & 2012 ...............................................51
Figure 6-7: Global - HIV Diagnostic and Monitoring Market (Million US$), 2004, 2008 & 2012 .................52
Figure 6-8: Global - Tuberculosis Diagnostic Market by Segment (%) .......................................................54
Figure 6-9: Global - Tuberculosis Detection and Monitoring Market by Segment (%), 2005......................54
Figure 6-10: Global - Influenza Diagnostic Market (Million US$), 2008-2012.............................................56
Figure 7-1: Global - In Vitro Diagnostic Market by Region (%), 2009 .........................................................57
Figure 7-2: Global - Forecast for In Vitro Diagnostic Market by Region (%), 2012.....................................58
Figure 7-3: US - In Vitro Diagnostic Market (Billion US$), 2007-2009 ........................................................59
Figure 7-4: US - In Vitro Diagnostic Market by Segment (%), 2007............................................................60
Figure 7-5: US - Labs in IVD Market by Type (%), 2008.............................................................................61
Figure 7-6: US - Forecast for In Vitro Diagnostic Market (Billion US$), 2010-2012....................................61
Figure 7-7: Canada - In Vitro Diagnostic Market (Million US$), 2007-2009 ................................................62
Figure 7-8: Canada - Forecast for In Vitro Diagnostic Market (Million US$), 2010-2012............................63
Figure 7-9: Europe - In Vitro Diagnostic Market (Billion Euro), 2007-2009.................................................64
Figure 7-10: Europe - In Vitro Diagnostic Market by Country (%), 2008.....................................................65
Figure 7-11: Europe - Forecast for In Vitro Diagnostic Market (Billion Euro), 2010-2012.........
								
To top